Mesothelioma is considered a terminal cancer because there is currently no cure. However, a mesothelioma diagnosis is not always immediately fatal. Some patients live for several years after diagnosis, particularly when the cancer is found early and responds well to treatment.
A patient’s prognosis depends on several factors, including the type and stage of mesothelioma, cancer cell type, age, overall health, and treatment options. Advances in surgery, chemotherapy, immunotherapy, and other therapies have also helped some patients live longer than expected.
A fatal disease is a medical condition that may eventually cause a patient’s death. A terminal illness generally refers to a disease that cannot be cured and is expected to shorten a person’s life.
Mesothelioma is an aggressive and incurable cancer. However, that does not mean every patient has the same outcome. Some people live only a few months after diagnosis, while others survive for several years with specialized treatment.
Doctors cannot predict exactly how long an individual patient will live. Survival statistics are estimates based on groups of patients and should not be viewed as a definite timeline.
Many patients with mesothelioma live for approximately one year after diagnosis, but individual survival times vary significantly. Some patients live for several years, especially when they are diagnosed earlier, have a favorable cell type, and qualify for aggressive treatment.
The location of the cancer can also affect survival. The primary types of mesothelioma include:
Pleural mesothelioma is the most common type. Peritoneal mesothelioma is less common but generally has better long-term survival outcomes, particularly among patients who qualify for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, or HIPEC.
A mesothelioma survival rate represents the percentage of patients who remain alive for a certain amount of time after diagnosis. A five-year survival rate, for example, represents the percentage of patients who are alive five years after their diagnosis.
Life expectancy is different from a survival rate. It estimates how long an individual patient may live based on factors such as:
A doctor can discuss how these factors may affect an individual’s prognosis, but no estimate can predict a patient’s exact outcome.
Find a Mesothelioma Lawyer
Pleural mesothelioma develops in the pleura, the thin tissue surrounding the lungs and lining the chest cavity. It is the most common form of mesothelioma.
Pleural mesothelioma can be difficult to diagnose early because symptoms such as shortness of breath, chest pain, fatigue, and coughing may resemble more common respiratory conditions. Many patients are not diagnosed until the cancer has already spread, which can limit treatment options.
Estimated pleural mesothelioma survival rates include:
These percentages represent general estimates rather than an individual patient’s expected outcome. Patients diagnosed at an earlier stage or with epithelioid mesothelioma may have a more favorable prognosis. Some patients may also live longer when they receive a combination of treatments from an experienced mesothelioma care team.
Peritoneal mesothelioma develops in the peritoneum, the tissue lining the abdominal cavity. It generally has better survival outcomes than pleural mesothelioma.
Estimated peritoneal mesothelioma survival rates include:
One reason for the higher survival rates is the availability of cytoreductive surgery combined with heated intraperitoneal chemotherapy (HIPEC) for eligible patients. During this procedure, surgeons remove as much visible cancer as possible before applying heated chemotherapy directly inside the abdominal cavity. This approach may destroy cancer cells that remain after surgery.
Not every patient qualifies for surgery and HIPEC. Eligibility may depend on the extent of the cancer, the patient’s overall health, and whether the tumors can be safely removed. Patients should speak with a peritoneal mesothelioma specialist to learn whether this treatment may be appropriate.
Some people become long-term mesothelioma survivors. Although there is no cure, certain patients have lived five, 10, or more years after diagnosis.
Long-term survival is more likely among patients who:
Peritoneal mesothelioma patients who qualify for surgery and HIPEC may be especially likely to live beyond average survival estimates.
Long-term survival is not guaranteed, and every case is different. However, survival statistics cannot determine exactly how one person will respond to treatment.
Mesothelioma is not currently curable. Even when doctors remove all visible tumors, microscopic cancer cells may remain and cause the disease to return.
In rare cases, a patient may experience remission. Remission means the signs and symptoms of cancer have decreased or disappeared. It does not necessarily mean that the cancer has been permanently cured.
Treatments can still provide important benefits. Depending on the patient and stage of the disease, treatment may:
Researchers continue to study immunotherapy, targeted therapy, tumor treating fields, new drug combinations, and other approaches through mesothelioma clinical trials.
No single factor determines how long a mesothelioma patient will live. Doctors consider several details when estimating a patient’s prognosis.
Mesothelioma treatment depends on where the cancer began, how far it has spread, the patient’s overall health, and the goals of care.
Surgery may remove tumors and affected tissue in eligible patients. The procedures used for pleural mesothelioma differ from those used for peritoneal mesothelioma.
Chemotherapy drugs travel through the bloodstream or may be delivered directly to the area containing cancer. Chemotherapy may be used before surgery, after surgery, or as the primary treatment when surgery is not appropriate.
Immunotherapy helps the immune system identify and attack cancer cells. Certain immunotherapy combinations may be used to treat unresectable pleural mesothelioma.
Radiation uses high-energy beams to destroy cancer cells. Doctors may use it to control a specific tumor, relieve pain, or reduce the likelihood of cancer returning in a treated area.
Tumor treating fields use alternating electrical fields intended to interfere with cancer cell division. They may be combined with chemotherapy for certain patients with pleural mesothelioma.
Clinical trials evaluate new treatments or new combinations of existing therapies. Participating in a trial may give an eligible patient access to a treatment that is not yet widely available.
Mesothelioma treatment may involve appointments with specialists, travel, surgery, medications, hospital stays, and ongoing supportive care. Even patients with health insurance may experience high out-of-pocket costs.
Potential sources of financial support may include:
Some clinical trials cover the cost of the treatment being studied, but patients or insurers may remain responsible for routine medical care, travel, and other expenses. Patients should ask the research team which costs are covered before enrolling.
Treatment may help patients live longer, manage symptoms, and maintain a better quality of life. Doctors may use one treatment or combine several therapies based on the type and stage of mesothelioma.
Treatment options may include:
For pleural mesothelioma, doctors may combine surgery with chemotherapy, immunotherapy, or radiation therapy in eligible patients. Surgery is rarely used alone because mesothelioma can spread along the surfaces of the chest and may be difficult to remove completely.
For peritoneal mesothelioma, cytoreductive surgery combined with HIPEC may significantly improve survival among qualifying patients. During cytoreductive surgery, doctors remove visible tumors and affected tissue from the abdomen. Heated chemotherapy is then circulated within the abdominal cavity to target remaining cancer cells.
Treatment outcomes vary, and a therapy that helps one patient may not be appropriate for another. Patients should discuss potential benefits, side effects, and treatment goals with a mesothelioma specialist.
Without treatment, mesothelioma generally continues to grow and spread. However, it is difficult to provide a single life expectancy estimate because the disease progresses differently in each patient.
Some people may not receive cancer-directed treatment because:
Patients who do not qualify for aggressive treatment may still receive palliative care. Palliative treatments do not attempt to cure the cancer, but they can relieve pain, breathing problems, fluid buildup, fatigue, and other symptoms.
Palliative care can be provided alongside cancer treatment and is not limited to the final stages of the disease. Hospice care may also support patients and families when treatment is no longer controlling the cancer.
A doctor familiar with the patient’s diagnosis and overall health can provide the most appropriate information about what to expect without treatment.
Mesothelioma is typically diagnosed through imaging tests and a biopsy. Imaging may show an abnormal mass or fluid buildup, but a biopsy is generally needed to confirm the cancer and identify its cell type.
After receiving a diagnosis, consider taking the following steps:
Patients should talk with their care teams before making major dietary or exercise changes. Healthy food, appropriate physical activity, rest, and emotional support may help patients maintain strength, but these measures do not cure mesothelioma or replace medical treatment.
Asbestos exposure is the primary cause of mesothelioma. Many patients encountered asbestos at work, during military service, through contaminated products, or from fibers brought home on another person’s clothing.
Companies that manufactured, distributed, or used asbestos-containing products may have failed to warn workers and consumers about the risks. Patients and their families may qualify for compensation through:
Compensation may help cover medical bills, lost income, travel expenses, caregiving, and other costs related to a diagnosis. Eligibility and filing deadlines vary, so patients and families may benefit from speaking with an experienced mesothelioma attorney.
Mesothelioma is considered a terminal cancer because there is currently no cure. However, the amount of time a patient lives after diagnosis varies. Some patients live for several years with treatment.
Yes. Some patients have lived five, 10, or more years after a mesothelioma diagnosis. Long-term survival is more common among patients with favorable prognostic factors who qualify for specialized treatment.
Many patients live for approximately one year after diagnosis, but life expectancy varies widely. Mesothelioma type, stage, cell type, overall health, and treatment response can all affect survival.
Peritoneal mesothelioma generally has better long-term survival rates than pleural mesothelioma. Some eligible peritoneal patients experience significantly longer survival after cytoreductive surgery and HIPEC.
Treatment may slow the cancer, manage symptoms, and extend survival. Patients who qualify for surgery or multimodal treatment may live longer than those who cannot receive cancer-directed treatment, although outcomes vary.
Mesothelioma can sometimes enter partial or complete remission, meaning the signs of cancer decrease or temporarily disappear. Because the disease may return, doctors usually continue monitoring patients after treatment.
The rate of progression differs from patient to patient. Mesothelioma type, stage, and cell type can affect how quickly the cancer grows and spreads. Imaging tests and follow-up appointments help doctors monitor changes over time.
So, is mesothelioma always fatal? Mesothelioma is an incurable and life-threatening cancer, but survival differs significantly among patients. A prognosis is an estimate, not a fixed deadline.
Advances in surgery, chemotherapy, immunotherapy, and specialized procedures have helped some patients live much longer than average. Consulting an experienced mesothelioma specialist can help patients better understand their diagnosis, compare treatment options, and make informed decisions about their care.
Patients and families may also have medical, emotional, and financial resources available to help them throughout the treatment process. An experienced mesothelioma attorney can help determine whether compensation may be available to pay for treatment, caregiving, travel, and other expenses, or to help make a patient’s final months more comfortable. Families who have lost a loved one may also be able to pursue compensation through a wrongful death claim and hold the companies responsible for asbestos exposure accountable.
Madeline works for the patient advocate team and writes about asbestos exposure and mesothelioma. She is passionate about helping families in the mesothelioma community.
American Cancer Society. (n.d.). Survival rates for pleural mesothelioma. Retrieved July 23, 2026, from https://www.cancer.org/cancer/types/malignant-mesothelioma/detection-diagnosis-staging/survival-statistics.html
PDQ Adult Treatment Editorial Board. (2025, May 12). Malignant mesothelioma treatment (PDQ®)–Health professional version. National Cancer Institute. https://www.cancer.gov/types/mesothelioma/hp/mesothelioma-treatment-pdq
Shavelle, R., et al. (2017). Life Expectancy in Pleural and Peritoneal Mesothelioma. Retrieved on February 23, 2022, from https://ncbi.nlm.nih.gov/pmc/articles/PMC5292397/
Valenzuela, C. D., Solsky, I. B., Erali, R. A., Forsythe, S. D., Mangieri, C. W., Mainali, B. B., Russell, G., Perry, K. C., Votanopoulos, K. I., Shen, P., & Levine, E. A. (2023). Long-term survival in patients treated with cytoreduction and heated intraperitoneal chemotherapy for peritoneal mesothelioma at a single high-volume center. Annals of Surgical Oncology, 30, 2666–2675. https://doi.org/10.1245/s10434-022-13061-3